IperionX price target raised to $32 from $24.50 at Alliance Global Partners

Alliance Global Partners raised the firm’s price target on IperionX (IPX) to $32 from $24.50 and keeps a Buy rating on the shares. The company announced 2024 results and provided a corporate update with respect to its titanium manufacturing facility in Virginia, the analyst tells investors in a research note. The firm believes the stage is set for production to ramp and views 2025 as “catalyst-rich” for IperionX. It expects the titanium production ramp to serve as an inflection point for the shares.